Washington Business Journals Names Brian Ferdinand as a 2026 Projected Breakout Trader

Washington Business Journals Names Brian Ferdinand as a 2026 Projected Breakout Trader GlobeNewswire January 12, 2026 Washington, DC, Jan. 12, 2026 (GLOBE NEWSWIRE) — Washington Business Journals has named Brian Ferdinand as one of its 2026 Projected Breakout Traders, recognizing his disciplined approach to markets, long-term vision, and evolving leadership in modern trading. The designation […]

GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL

(NYSE:GTN),(NYSE:GTN-A), ATLANTA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended, December 31, 2025, on Thursday, February 26, 2026. Earnings Conference Call Information Gray Media, Inc. will host a conference call to discuss its operating results for the quarter ended

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. – RZLT

NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Rezolute, Inc. ("Rezolute" or the "Company") (NASDAQ:RZLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Rezolute and certain of its officers and/or directors

GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL

GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL GlobeNewswire January 12, 2026 ATLANTA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended, December 31, 2025, on Thursday, February 26, 2026. Earnings Conference Call Information Gray Media,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated – INSM

NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ:INSM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Insmed and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of – GALT

NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Galectin Therapeutics Inc. ("Galectin" or the "Company") (NASDAQ:GALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galectin and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics – NKTR

NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ:NKTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nektar and certain of its officers and/or directors

Leading Public Health Groups Seek Expedited Injunctive Relief Against Immunization Schedule Changes, Upcoming ACIP Meeting; Hearing Scheduled Friday, February 13

— Plaintiffs in AAP v. Kennedy will seek to enjoin the February 25-26 ACIP meeting to prevent it from taking place. — Plaintiffs will ask the Court to vacate the January 5 changes to the pediatric immunization schedule and restore the childhood schedule to what it was as of April 15, 2025. — Plaintiffs will

Scroll to Top